Discovery On Target (DOT)
About the event:
30th September to 3rd October 2024, Boston, Massachusetts, USA
This year’s discovery on target has been marked by significant advancements in precision medicine, with a strong focus on identifying and validating novel drug targets that have the potential to revolutionize treatment strategies. Researchers and pharmaceutical companies have made considerable progress in understanding disease mechanisms at a molecular level, leading to the development of more effective and targeted therapies. The integration of cutting-edge technologies such as CRISPR, AI-driven drug discovery, and high-throughput screening has accelerated the pace of discovery, offering new hope for tackling complex diseases that were previously deemed untreatable
Taros participants:
Dr. Anil Agarwal, Head Medicinal Chemist 
Youri Mesmoudi, Executive Vice President
To make an appointment in advance please click on participants name or the contact button below
Are you going to attend the event? Contact us in advance to arrange a meeting
Drug Discovery Chemistry
Medicinal Chemistry
In Medicinal Chemistry research, we are working with a broadly experienced team on all biomolecular targets from any gene family in any therapeutic area…
Discovery Chemistry
Custom Synthesis
As a leading Contract Research Organization in Europe, Taros provides valuable contract discovery for synthetic organic chemistry, chemical process development, and…
